How should a skin rash caused by Stafloxin (flucloxacillin) be managed?

Management of Stafloxin (Flucloxacillin)-Induced Skin Rash

Immediately discontinue flucloxacillin at the first sign of any skin rash, as this drug can cause severe and potentially fatal cutaneous reactions including Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). 1

Immediate Assessment and Action

Severity Classification

First, determine if the rash is severe or non-severe:

Severe reactions (discontinue immediately and hospitalize):

• Tiny vesicles, crusts, or grey-violaceous/dusky lesions
• Painful or burning skin with fever and malaise
• Hemorrhagic erosions of mucous membranes
• Skin detachment (SJS/TEN)
• Facial edema with fever ≥38.5°C
• Pustular eruptions
• Purpura (vasculitis)
• Involvement of >50% body surface area 2

Non-severe reactions:

• Isolated urticaria, erythema, or pruritus
• Maculopapular exanthema without systemic symptoms 2

Critical Warning Signs

Look specifically for:

• Positive Nikolsky sign (skin sloughing with gentle pressure)
• Mucosal involvement (oral, ocular, genital)
• Systemic symptoms (fever, lymphadenopathy, eosinophilia)
• Rapid progression over 24-48 hours 1

Management Algorithm

For Severe Reactions (SJS/TEN or DRESS)

1. Stop flucloxacillin immediately - do not rechallenge 1

2. Hospitalize with intensive supportive care:

   • IV fluids and electrolyte management
   • Wound care similar to burn management
   • Daily skin swabs to monitor for secondary infection 1

3. Systemic corticosteroids:

   • Methylprednisolone 0.5-2 mg/kg/day IV
   • Taper over 4-6 weeks 3

4. Consider IVIG (intravenous immunoglobulin) for TEN 1

5. Monitor for secondary bacterial infection:

   • Staphylococcus aureus is most common
   • If infection develops, use IV teicoplanin or vancomycin (avoid all beta-lactams including flucloxacillin) 1, 4

For Non-Severe Reactions

1. Discontinue flucloxacillin 2

2. Topical management:

   • Topical corticosteroids (prednicarbate cream 0.02%) for erythema and inflammation 5
   • Emollients and moisturizers applied at least once daily 5
   • Avoid alcohol-containing lotions 5

3. Systemic treatment if needed:

   • Oral H1-antihistamines (cetirizine, loratadine, or fexofenadine) for pruritus 5
   • Short-term oral corticosteroids for grade 3 erythema/desquamation 5

4. Monitor for progression - reassess within 24-48 hours

Alternative Antibiotic Selection

Never rechallenge with flucloxacillin after any hypersensitivity reaction. 2

Cross-Reactivity Considerations

• Immediate (IgE-mediated) reactions: Only 35% show cross-reactivity with other penicillins on testing 6
• Delayed (T-cell-mediated) reactions: 75% show cross-reactivity with other penicillins 6

Safe Alternatives Based on Reaction Type

For immediate-type reactions (urticaria, angioedema, anaphylaxis):

• Avoid all penicillins (including amoxicillin, ampicillin)
• Avoid cephalosporins with similar side chains
• Safe options: Vancomycin, linezolid, daptomycin, or fluoroquinolones 2

For delayed-type non-severe reactions:

• Avoid all penicillins
• Avoid cephalosporins with similar side chains
• Carbapenems and aztreonam may be used with caution in a monitored setting 2

For severe cutaneous reactions (SJS/TEN/DRESS):

• Avoid ALL beta-lactam antibiotics permanently 2
• Use glycopeptides (vancomycin, teicoplanin), linezolid, or daptomycin for staphylococcal coverage 4, 1

Common Pitfalls to Avoid

1. Do not continue flucloxacillin "to see if the rash improves" - this led to fatal TEN in documented cases 1

2. Do not use topical acne medications or retinoids - these worsen drug-induced rashes through drying effects 5

3. Do not assume mild rashes are benign - SJS/TEN can begin as simple maculopapular eruptions and progress rapidly 1

4. Do not use greasy creams - these may facilitate secondary folliculitis 5

5. Do not prescribe other beta-lactams without allergy testing if the reaction was severe or delayed-type 2

Documentation Requirements

Document in the medical record:

• Exact timing of rash onset relative to drug initiation
• Morphology and distribution of rash
• Presence/absence of mucosal involvement
• Systemic symptoms (fever, lymphadenopathy)
• Label as "flucloxacillin allergy - avoid all beta-lactams" for severe reactions 2

The case fatality rate for flucloxacillin-induced TEN can be significant even with aggressive treatment, emphasizing the critical importance of early drug discontinuation. 1